There is, however, a ray of hope for those who are 'critical'
SANOFI. File photo of Mourenx site from Sanofi's official websiteCOVID-19Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus but instead inhibits an abnormal immune response called a"cytokine storm" that causes the lungs of the sickest patients to become inflamed, leaving them fighting for their lives on ventilators.
There was, however, a ray of hope for those who were"critical," defined as needing mechanical ventilation or high-flow oxygenation. In this group, 44 were on a placebo, 94 were given a low dose and 88 were given a high dose.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DOH: 1,245 healthcare workers test positive for coronavirus; 27 dieA total of 1,245 health care professionals have so far been infected with the novel coronavirus or SARS-CoV-2 which causes the coronavirus disease 2019. | DYGalvezINQ
Read more »
Cebu City records 40 new COVID-19 casesCebu City records 40 new coronavirus infections, pushing the total number to 451.
Read more »
How can the Philippines secure enough drugs or vaccines against coronavirus?Researchers from the De La Salle University say that once effective treatments against COVID-19 become available, there will be a challenge to produce enough supply to match worldwide demand. COVID19PH
Read more »
Regeneron, Sanofi to treat only 'critical' COVID-19 patients with arthritis drug
Read more »
Back at work, coronavirus-hit British PM warns against easing lockdown
Read more »
Turkey detains over 400 over 'provocative' coronavirus posts
Read more »